• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CoorsTek Medical Becomes Lincotek Medical

Share:

October 15, 2019

Rebranding the recent acquisition to Lincotek Medical is the first step to integrate the entity into the global medical business and begins the group’s rebranding initiative.

Unitedcoatings Group announces today that following its acquisition of CoorsTek Medical in July of 2019, the entity will be rebranded as Lincotek Medical. Not only does this begin the integration of the newly acquired entity into its global medical business to create customer focused integrated supply chain solutions, it also kicks off the rebranding of the entire group to better communicate the complete global offering to customers. “This is the first step in our global rebranding initiative under the name ‘Lincotek,’” says Winfried Schaller, CEO of Unitedcoatings Group. “The Groups’ success under its different brands has been impressive and now it’s time to present ourselves under one coherent brand while leveraging the goodwill of our current brands including Turbocoating, Artec, Eurocoating, Surface Dynamics, Anteco, NanoSurfaces, Eurocoating Wuxi and, now CoorsTek Medical.”

The newly branded Lincotek Medical, part of the global medical division, adds to the groups’ abilities and makes it one of the largest fully integrated outsource service providers in the Medical Device market. Combining the development engineering and manufacturing expertise with the market leading coating and additive manufacturing capabilities of Unitedcoatings Group provides OEM customers with a unique and comprehensive portfolio of services positioning the company as the obvious choice for medical innovators and medical device providers worldwide.

While this is a significant change, our core beliefs remain the same. We remain committed to providing “Excellence in Medical Device Solutions” and will continue to focus on our customers’ needs while ensuring the level of professionalism our customers have come to expect with quality products, on time deliveries, and exceptional customer service.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Business Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Crh Medical Corporation Announces Majority Purchase of Florida Panhandle Anesthesia AssociatesCrh Medical Corporation Announces Majority Purchase of Florida Panhandle Anesthesia Associates
  • COVID-19: National Medical Device Registry Launches To Track Ventilators For HospitalsCOVID-19: National Medical Device Registry Launches To Track Ventilators For Hospitals
  • Asthma Treatment Market Key Insights and Booming Factor Supporting Growth Till 2027Asthma Treatment Market Key Insights and Booming Factor Supporting Growth Till 2027
  • Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium BenzoateAcer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
  • Northwell, Allscripts To Co-Create Voice-Enabled, AI-Driven EHR Platform  Northwell , Allscripts To Co-Create Voice-Enabled , AI-Driven EHRNorthwell, Allscripts To Co-Create Voice-Enabled, AI-Driven EHR Platform Northwell , Allscripts To Co-Create Voice-Enabled , AI-Driven EHR
  • Impact of COVID-19 on Pharmaceutical Grade HPMC MarketImpact of COVID-19 on Pharmaceutical Grade HPMC Market
  • Validant Acquires DataRevive, a Regulatory Strategy and Consulting Business Focused on Novel Therapeutics and BiologicsValidant Acquires DataRevive, a Regulatory Strategy and Consulting Business Focused on Novel Therapeutics and Biologics
  • Science Interactive Group Acquires Escience LabsScience Interactive Group Acquires Escience Labs

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications